Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Drucker

Showing results (51-60 of 313) with videos related to

Pageof 32
Sort By:
Physiology (Bethesda, Md.)|September 22, 2005
Proglucagon-derived peptides: mechanisms of action and therapeutic potentialElaine M Sinclair, Daniel J Drucker
Cell Metabolism|May 21, 2013
Pharmacology, physiology, and mechanisms of incretin hormone actionJonathan E Campbell, Daniel J Drucker
Nature Medicine|October 9, 2013
Metabolic disease puts up a fight: are diet and exercise helpful for the heart?Julie A Lovshin, Daniel J Drucker
Diabetes Care|January 31, 2006
Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1Matthew C Riddle, Daniel J Drucker
Circulation Research|May 24, 2014
Cardiovascular actions of incretin-based therapiesJohn R Ussher, Daniel J Drucker
Endocrine Reviews|February 11, 2012
Cardiovascular biology of the incretin systemJohn R Ussher, Daniel J Drucker
Treatments in Endocrinology|March 16, 2005
Harnessing the therapeutic potential of glucagon-like peptide-1: a critical reviewLaurie L Baggio, Daniel J Drucker
Diabetes|February 29, 2008
Beta-cell replication by loosening the brakes of glucagon-like peptide-1 receptor signalingFrans C Schuit, Daniel J Drucker
Nature Reviews. Cardiology|March 28, 2023
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of actionJohn R Ussher, Daniel J Drucker
Diabetologia|March 28, 2023
The expanding incretin universe: from basic biology to clinical translationDaniel J Drucker, Jens J Holst
Pageof 32

Showing results (51-60 of 313) with videos related to

Sort By:
Pageof 32
Physiology (Bethesda, Md.)|September 22, 2005
Proglucagon-derived peptides: mechanisms of action and therapeutic potentialElaine M Sinclair, Daniel J Drucker
Cell Metabolism|May 21, 2013
Pharmacology, physiology, and mechanisms of incretin hormone actionJonathan E Campbell, Daniel J Drucker
Nature Medicine|October 9, 2013
Metabolic disease puts up a fight: are diet and exercise helpful for the heart?Julie A Lovshin, Daniel J Drucker
Diabetes Care|January 31, 2006
Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1Matthew C Riddle, Daniel J Drucker
Circulation Research|May 24, 2014
Cardiovascular actions of incretin-based therapiesJohn R Ussher, Daniel J Drucker
Endocrine Reviews|February 11, 2012
Cardiovascular biology of the incretin systemJohn R Ussher, Daniel J Drucker
Treatments in Endocrinology|March 16, 2005
Harnessing the therapeutic potential of glucagon-like peptide-1: a critical reviewLaurie L Baggio, Daniel J Drucker
Diabetes|February 29, 2008
Beta-cell replication by loosening the brakes of glucagon-like peptide-1 receptor signalingFrans C Schuit, Daniel J Drucker
Nature Reviews. Cardiology|March 28, 2023
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of actionJohn R Ussher, Daniel J Drucker
Diabetologia|March 28, 2023
The expanding incretin universe: from basic biology to clinical translationDaniel J Drucker, Jens J Holst
Pageof 32